NVCT – nuvectis pharma, inc. (US:NASDAQ)
Stock Stats
News
Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug [Yahoo! Finance]
Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer [Yahoo! Finance]
Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer
Nuvectis Pharma GAAP EPS of -$0.24 beats by $0.01 [Seeking Alpha]
Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights
Form 4 Nuvectis Pharma, Inc. For: Nov 19 Filed by: Poradosu Enrique
Form 4 Nuvectis Pharma, Inc. For: Nov 15 Filed by: BENTSUR RON
Form 4 Nuvectis Pharma, Inc. For: Jan 03 Filed by: Carson Michael J.
Form SC 13G/A Nuvectis Pharma, Inc. Filed by: Pontifax Management 4 G.P. (2015) Ltd.
Form 10-Q Nuvectis Pharma, Inc. For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.